Rentschler Biopharma SE
Effective since January 15, Dr. Christian Hunzinger is the new senior vice president of project management at the CDMO.
Hunzinger has more than 15 years of industry experience and succeeds the previous CEO Dr. Klaus Schoepe, who will retire later this year after working more than 14 years for the company.
Hunzinger previously was the biotech CMC program lead at Merck, a role in which he was responsible for all issues relating to CMC development.
He held several roles at Merck, and started his career as a research scientist at ProteoSys AG.